UBS Group AG (SWX:UBSG)
30.32
+0.25 (0.83%)
Feb 21, 2025, 5:31 PM CET
UBS Group AG Employees
UBS Group AG had 108,648 employees as of December 31, 2024. The number of employees decreased by 4,194 or -3.72% compared to the previous year.
Employees
108,648
Change (1Y)
-4,194
Growth (1Y)
-3.72%
Revenue / Employee
400.84K CHF
Profits / Employee
42.41K CHF
Market Cap
96.26B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 108,648 | -4,194 | -3.72% |
Dec 31, 2023 | 112,842 | 40,245 | 55.44% |
Dec 31, 2022 | 72,597 | 1,212 | 1.70% |
Dec 31, 2021 | 71,385 | -166 | -0.23% |
Dec 31, 2020 | 71,551 | 2,950 | 4.30% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Jan 1, 2017 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
Company Name | Employees |
---|---|
Zurich Insurance Group AG | 60,000 |
Swiss Re AG | 14,719 |
Partners Group Holding AG | 1,931 |
Swiss Life Holding AG | 10,971 |
Julius Bär Gruppe AG | 7,595 |
Helvetia Holding AG | 13,812 |
Banque Cantonale Vaudoise | 2,089 |
Swissquote Group Holding | 1,033 |
UBS Group AG News
- 1 day ago - Top Holders Of Quantum Computing Stocks In Q4: BlackRock, Vanguard, UBS, State Street Pour Money In Rigetti, D-Wave, IonQ, QUBT - Benzinga
- 2 days ago - TMX VettaFi Acquires Credit Suisse Bond Indices From UBS - Newsfile Corp
- 2 days ago - ANALYSE-FLASH: Morgan Stanley senkt UBS auf 'Equal-weight', Ziel auf 34 Franken - Onvista
- 3 days ago - UBS Group AG Celebrates Recognition of The Matthews Group in Forbes Wealth Management Rankings - GuruFocus
- 4 days ago - UBS Advisor Team The Matthews Group Named to Forbes Top Wealth Management Teams and Best-in-State Lists - Business Wire
- 4 days ago - Ahead Of GameStop's Bitcoin Purchase Plans, BlackRock, Morgan Stanley, Goldman Sachs, And Other Billion Dollar Funds Load Up On GME Stock In Q4 - Benzinga
- 6 days ago - UBS offers sabbatical perk to former Credit Suisse staff only - Financial Times
- 9 days ago - AstraZeneca upgraded by UBS to buy on growth potential - Seeking Alpha